Gastroesophageal reflux disease: Medical or surgical treatment?

Gastroenterology Research and Practice

Volumn , Issue , 2009, Pages

  Liakakos, Theodore ^a   Karamanolis, George ^a   Patapis, Paul ^a   Misiakos, Evangelos P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; CIMETIDINE; CISAPRIDE; ESOMEPRAZOLE; FAMOTIDINE; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; RANITIDINE; TEGASEROD; TRAZODONE;

ANALGESIC ACTIVITY; ANTIREFLUX OPERATION; COMPARATIVE STUDY; DIETARY INTAKE; DRUG BINDING; DRUG WITHDRAWAL; DYSPHAGIA; ENDOLUMINAL GASTROPLICATION; ESOPHAGEAL PH MONITORING; ESOPHAGOSCOPY; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEART ARRHYTHMIA; HEARTBURN; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; PATHOPHYSIOLOGY; PATIENT SATISFACTION; REFLUX ESOPHAGITIS; REVIEW; STOMACH FUNDOPLICATION; SURGICAL TECHNIQUE; VOMITING;

EID: 77955199027     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2009/371580     Document Type: Review

References (172)

1. O. T. Nebel, M. E. Fornes, and D. O. Castell, "Symptomatic gastroesophageal reflux: incidence and precipitating factors," American Journal of Digestive Diseases, vol. 21, no. 11, pp. 953-956, 1976.
2. T. R. DeMeester, L. F. Johnson, G. J. Joseph, M. S. Toscano, A. W. Hall, and D. B. Skinner, "Patterns of gastroesophageal reflux in health and disease," Annals of Surgery, vol. 184, no. 4, pp. 459-470, 1976.
3. S. Nandurkar and N. J. Talley, "Epidemiology and natural history of reflux disease," Baillieres Best Practice and Research in Clinical Gastroenterology, vol. 14, no. 5, pp. 743-757, 2000.
4. R. H. Hunt, G. H. Tytgat, P. Malfertheiner, et al., "Whistler summary: the slow rate of rapid progress," Journal of Clinical Gastroenterology, vol. 41, no. 6, pp. 539-545, 2007.
5. H. Miwa, "Natural history and new conceptual framework of gastroesophageal reflux disease," Journal of Gastroenterology, vol. 41, no. 5, pp. 509-510, 2006.
6. K. M. Fock, N. Talley, R. Hunt, et al., "Report of the AsiaPacific consensus on the management of gastroesophageal reflux disease," Journal of Gastroenterology and Hepatology, vol. 19, no. 4, pp. 357-367, 2004.
7. K. Iwakiri, M. Kobayashi, M. Kotoyori, H. Yamada, T. Sugiura, and Y. Nakagawa, "Relationship between postprandial esophageal acid exposure and meal volume and fat content," Digestive Diseases and Sciences, vol. 41, no. 5, pp. 926-930, 1996.
8. H. Hampel, N. S. Abraham, and H. B. El-Serag, "Metaanalysis: obesity and the risk for gastroesophageal reflux disease and its complications," Annals of Internal Medicine, vol. 143, no. 3, pp. 199-211, 2005.
9. J. P. Galmiche and S. Bruley des Varannes, "Symptoms and disease severity in gastroesophageal reflux disease," Scandinavian Journal of Gastroenterology, vol. 29, supplement 201, pp. 62-68, 1994.
10. N. Vakil, S. V. van Zanten, P. Kahrilas, J. Dent, and R. Jones, "The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus," The American Journal of Gastroenterology, vol. 101, pp. 1900-1920, 2006.
11. N. Vakil, "The frontiers of reflux disease," Digestive Diseases and Sciences, vol. 51, no. 11, pp. 1887-1895, 2006.
12. B. B. Dean, D. Aguilar, L. F. Johnson, et al., "The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity," Digestive Diseases and Sciences. In press.
13. T. R. DeMeester, L. Bonavina, and M. Albertucci, "Nissen fundoplication for gastroesophageal reflux disease: evaluation of primary reflux in 100 consecutive patients," Annals of Surgery, vol. 204, pp. 9-20, 1986.
14. S. J. Spechler, "Epidemiology and natural history of gastroesophageal reflux disease," Digestion, vol. 51, supplement 1, pp. 24-29, 1992.
15. H. B. El-Serag and A. Sonnenberg, "Associations between different forms of gastro-oesophageal reflux disease," Gut, vol. 41, no. 5, pp. 594-599, 1997.
16. F. Pace and G. B. Porro, "Gastroesophageal reflux disease: a typical spectrum disease (A new conceptual framework is not needed)" The American Journal of Gastroenterology, vol. 99, no. 5, pp. 946-949, 2004.
17. J. Labenz, M. Nocon, T. Lind, et al., "Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease," The American Journal of Gastroenterology, vol. 101.no. 11, pp. 2457-2462, 2006.
18. R. Fass and J. J. Ofman, "Gastroesophageal reflux diseaseshould we adopt a conceptual framework?" The American Journal of Gastroenterology, vol. 97, pp. 1901-1919, 2002.
19. R. Fass, "Distinct phenotypic presentations of gastroesophageal reflux disease: a new view of the natural history," Digestive Diseases, vol. 22, no. 2, pp. 100-107, 2004.
20. S. J. Sontag, A. Sonnenberg, T. G. Schnell, J. Leya, and A. Metz, "The long-term natural history of gastroesophageal reflux disease," Journal of Clinical Gastroenterology, vol. 40, no. 5, pp. 398-404, 2006.
21. T. Navarro-Rodriquez and R. Fass, "Functional heartburn, nonerosive reflux disease, and reflux esophagitis are all distinct conditions-a debate; pro," Current Treatment Options in Gastroenterology, vol. 10, no. 4, pp. 294-304, 2007.
22. D. Ang, K. Blondeau, D. Sifrim, and J. Tack, "The spectrum of motor function abnormalities in gastroesophageal reflux disease and Barrett's esophagus," Digestion, vol. 79, no. 3, pp. 158-168, 2009.
23. A. J. Cameron, B. J. Ott, and W. S. Payne, "The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus," The New England Journal of Medicine, vol. 313, pp. 857-859, 1985.
24. R. K. Mittal and D. H. Balaban, "The esophagogastric junction," The New England Journal of Medicine, vol. 336, no. 13, pp. 924-932, 1997.
25. G. Clemente, D. D'Ugo, P. Granone, et al., "Intraoperative esophageal manometry in surgical treatment of achalasia: a reappraisal," Hepatogastroenterology, vol. 43, no. 12, pp. 1532-1536, 1996.
26. M. N. Schoeman, M. D. Tippett, L. M. Akkermans, et al., "Mechanisms of gastroesophageal reflux in ambulatory healthy human subjects," Gastroenterology, vol. 108, pp. 83-91, 1995.
27. G. Karamanolis and D. Sifrim, "Developments in pathogenesis and diagnosis of gastroesophageal reflux disease," Current Opinion in Gastroenterology, vol. 23, no. 4, pp. 428-433, 2007.
28. G. M. Campos, J. H. Peters, T. R. DeMeester, et al., "The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease," Archives of Surgery, vol. 134, no. 8, pp. 882-888, 1999.
29. R. Penagini, M. N. Schoeman, J. Dent, et al., "Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis," Neurogastroenterology and Motility, vol. 8, no. 2, pp. 131-141, 1996.
30. J. L. Smith, A. R. Opekun, E. Larkai, and D. Y. Graham, "Sensitivity of esophageal mucosa to pH in gastroesophageal reflux disease," Gastroenterology, vol. 96, no. 3, pp. 683-689, 1989.
31. M. Vela, L. Camacho-Lobato, R. Srinivasan, et al., "Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole," Gastroenterology, vol. 120, no. 7, pp. 1599-1606, 2001.
32. F. Zerbib, S. Roman, A. Ropert, et al., "Esophageal pHimpedance monitoring and symptom analysis in GERD: a study in patients off and on therapy," The American Journal of Gastroenterology, vol. 101, no. 9, pp. 1956-1963, 2006.
33. J. Tack, G. Koek, I. Demends, et al., "Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?" The American Journal of Gastroenterology, vol. 99, pp. 981-988, 2004.
34. A. Brillantine, L. Monaco, M. Schettino, et al., "Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease," European Journal of Gastroenterology and Hepatology, vol. 20, no. 12, pp. 1136-1143, 2008.
35. M. G. Patti, H. I. Goldberg, M. Arcerito, et al., "Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury," American Journal of Surgery, vol. 171, no. 1, pp. 182-186, 1996.
36. S. Emerenziani, F. I. Habib, M. Ribolsi, et al., "Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients," Alimentary Pharmacology and Therapeutics, vol. 23, no. 6, pp. 751-757, 2006.
37. E. J. S. Boyd, "The prevalence of oesophagitis in patients with duodenal ulceration," The American Journal of Gastroenterology, 91, pp. 1539-1543, 1996.
38. S. Ohara, H. Sekine, K. Iijima, et al., "Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly," Japanese Journal of Gastroenterology, vol. 93, no. 4, pp. 235-239, 1996.
39. J. M. Lee and C. A. O'Morain, "Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?" Gut, vol. 43, supplement 1, pp. S14-S20, 1998.
40. R. C. Souza and J. H. Lima, "Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship," Diseases of the Esophagus, vol. 22, no. 3, pp. 256-263, 2009.
41. M. Grande, F. Cadeddu, M. Villa, et al., "Helicobacter pylori and gastroesophageal reflux disease," "World Journal of Surgical Oncology, vol. 6, article 74, 2008.
42. M. Fox and I. Forgacs, "Gastroesophageal reflux disease," British Medical Journal, vol. 332, no. 7533, pp. 88-93, 2006.
43. D. Armstrong, J. R. Bennett, A. L. Blum, et al., "The endoscopic assessment of esophagitis: a progress report on observer agreement," Gastroenterology, vol. 111, no. 1, pp. 85-92, 1996.
44. J. Dent, J. Brun, A. M. Fendrick, et al., "An evidencebased appraisal of reflux disease management-The Genval Workshop Report," Gut, vol. 44, supplement 2, pp. 1-16, 1999.
45. D. R. Lichtenstein, B. D. Cash, R. Davila, et al., "Role of endoscopy in the management of GERD," Gastrointestinal Endoscopy, vol. 66, no. 2, pp. 219-224, 2007.
46. K. K. Wang and R. E. Sampliner, "Upadated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus," The American Journal of Gastroenterology, vol. 103, pp. 788-797, 2008.
47. N. Vakil, P. Moayyedi, M. B. Fennerty, et al., "Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: systematic review and meta-analysis," Gastroenterology, vol. 131, no. 2, pp. 390-401, 2006.
48. G. A. Prasad, N. J. Talley, Y. Romero, et al., "Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study," The American Journal of Gastroenterology, vol. 102, no. 12, pp. 2627-2632, 2007.
49. P. J. Kahrilas, N. J. Shaheen, and M. F. Vaezi, "American Gastroesophageal Association Institute Review on the management of gastroesophageal reflux disease," Gastroenterology, vol. 135, pp. 1392-1413, 2008.
50. H. J. Stein, A. P. Barlow, T. R. DeMeester, and R. A. Hinder, "Complications of gastroesophageal reflux disease," Annals of Surgery, vol. 216, no. 1, pp. 35-43, 1992.
51. J. E. Pandolfino and P. J. Kahrilas, "American Gastroenterological Association medical position statement: clinical use of esophageal manometry," Gastroenterology, vol. 128, no. 1, pp. 207-208, 2005.
52. A. Gasiorowska and R. Fass, "The proton pump inhibitor (PPI) test in GERD: does it still have a role?" Journal of Clinical Gastroenterology, vol. 42, no. 8, pp. 867-874, 2008.
53. R. Tutuian and D. O. Castell, "Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedancemanometry," Clinical Gastroenterology and Hepatology, vol. 2, no. 3, pp. 230-236, 2004.
54. J. E. Pandolfino, S. K. Ghosh, J. Rice, et al, "Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls," The American Journal of Gastroenterology, vol. 103, no. 1, pp. 27-37, 2008.
55. I. Hirano and J. E. Richter, "ACG practice guidelines: esophageal reflux testing," The American Journal of Gastroenterology, vol. 102, no. 3, pp. 668-685, 2007.
56. R. Fass and D. Sifrim, "Management of heartburn not responding to proton pump inhibitors," Gut, vol. 58, no. 2, pp. 295-309, 2009.
57. B. Kuo and D. O. Castell, "Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls," The American Journal of Gastroenterology, vol. 91, no. 8, pp. 1532-1538, 1996.
58. S. Charbel, F. Khandwala, and M. F. Vaezi, "The role of esophageal pH monitoring in symptomatic patients on PPI therapy," The American Journal of Gastroenterology, vol. 100, no. 2, pp. 283-289, 2005.
59. G. Karamanolis, T. Vanuytsel, D. Sifrim, et al., "Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy," Digestive Diseases and Sciences, vol. 53, no. 9, pp. 2387-2393, 2008.
60. F. Zerbib, A. Duriez, S. Roman, M. Capdepont, and F. Mion, "Determinants of gastro-esophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors," Gut, vol. 57, no. 2, pp. 156-160, 2008.
61. R. Fass, R. Hell, R. E. Sampliner, et al., "Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities," Digestive Diseases and Sciences, vol. 44, no. 11, pp. 2263-2269, 1999.
62. I. Hirano, Q. Zhang, J. E. Pandolfino, et al., "Bravo pH capsule monitoring with and without proton pump inhibitor therapy," Clinical Gastroenterology and Hepatology, vol. 3, no. 11, pp. 1083-1088, 2005.
63. D. Pohl and R. Tutuian, "Reflux monitoring: pH-metry, Bilitec and Oesophageal impedance measurements," Best Practice and Research & Clinical Gastroenterology, vol. 23, no. 3, pp. 299-311, 2009.
64. A. Agrawal and D. O. Castell, "Clinical importance of impedance measurements," Journal of Clinical Gastroenterology, vol. 42, no. 5, pp. 579-583, 2008.
65. I. Mainie, R. Tutuian, S. Shay, et al., "Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring," Gut, vol. 55, no. 10, pp. 1398-1402, 2006.
66. D. Sifrim, K. Blondeau, and L. Mantillla, "Utility of nonendoscopic investigations in the practical management of oesophageal disorders," Best Practice and Research & Clinical Gastroenterology, vol. 23, no. 3, pp. 369-386, 2009.
67. J. P. Galmiche, F. Zerbib, and S. Bruly des Varannes, "Review article: Respiratory manifestations of gastro-esophageal reflux disease," Alimentary Pharmacology & Therapeutics, vol. 27, pp. 449-464, 2008.
68. S. Shay, "A balancing view: impedance-Ph testing in GERD- limited role for now, perhaps more helpful in the future," The American Journal of Gastroenterology, vol. 104, pp. 2669-2670, 2009.
69. A. J. Bredenoord, B. L. Weusten, and A. J. Smout, "Symptom association analysis in ambulatory gastroesophageal reflux monitoring," Gut, vol. 54, pp. 1810-1817, 2005.
70. J. E. Richter, "Con: impedance-Ph testing does not commonly alter management in GERD," The American Journal of Gastroenterology, vol. 104, pp. 2667-2669, 2009.
71. P. Bechi, F. Pucciani, and F. Baldini, "Long-term ambulatory enterogastric reflux monitoring. Validation of a new fiberoptic technique," Digestive Diseases and Sciences, vol. 38, no. 7, pp. 1297-1306, 1993.
72. K. R. DeVault and D. O. Castell, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease," The American Journal of'Gastroenterology, vol. 100.no. 1,pp. 190-200, 2005.
73. K. R. DeVault and D. O. Castell, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease," The American Journal of Gastroenterology, vol. 94, no. 6, pp. 1434-1442, 1999.
74. D. J. Ott, Y. M. Chen, D. W. Gelfand, et al, "Analysis of a multiphasic radiographic examination for detecting reflux esophagitis," Gastrointestinal Radiology, vol. 11, pp. 1-6, 1986.
75. R. J. Sellar, J. S. DeCaestecker, and R. C. Heading, "Barium radiology: a sensitive test for gastro-esophageal reflux," Clinical Radiology, vol. 38, pp. 303-307, 1987.
76. Rome III: The Functional Gastrointestinal Disorders, Degnon Associates, McLean, Va, USA, 3rd edition, 2006.
77. R. F. Harvey, N. Hadley, T. R. Gill, et al, "Effects of sleeping with die bed-head raised and of ranitidine in patients with severe peptic oesophagitis," The Lancet, vol. 2, no. 8569, pp. 1200-1203, 1987.
78. B. W. A. Pfeiffer, C. Pehl, T. Schmidt, et al., "Effect of decaffeination of coffee or tea on gastro-oesophageal reflux," Alimentary Pharmacology & Therapeutics, vol. 8, pp. 283-287, 1994.
79. D. Y. Graham and D. J. Patterson, "Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis," Digestive Diseases and Sciences, vol. 28, no. 6, pp. 559-563, 1983.
80. D. A. Lieberman, "Medical therapy for chronic reflux esophagitis. Long term follow-up," Archives of Internal Medicine, vol. 147, pp. 717-720, 1987.
81. T. Poynard and French Cooperative Study Group, "Relapse rate of patients after healing of oesophagitis-a prospective study of alginate as self-care treatment for 6 months," Alimentary Pharmacology & Therapeutics, vol. 7, pp. 385-392, 1993.
82. A. L. Blum, "Treatment of acid-related disorders with gastric acid inhibitors: the state of the art," Digestion, vol. 47, supplement 1, pp. 3-10, 1990.
83. D. G. Colin-Jones, "The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease," Alimentary Pharmacology & Therapeutics, vol. 9, supplement 1, pp. 9-14, 1995.
84. R. Tutuian and D. O. Castell, "Management of gastroesophageal reflux disease," American Journal of the Medical Sciences, vol. 326, no. 5, pp. 309-318, 2003.
85. P. Richardson, C. J. Hawkey, and W. A. Stack, "Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders," Drugs, vol. 56, no. 3, pp. 307-335, 1998.
86. T. Pohle and W. Domschke, "Results of short- and longterm medical treatment of gastroesophageal reflux disease (GERD)," Langenbeck's Archives of Surgery, vol. 385, no. 5, pp. 317-323, 2000.
87. E. Klinkenberg-Knol, F. Nelis, J. Dent, et al., "Long-term omeprazole treatment in resistant gastroesophageal reflux disease," Gastroenterology, vol. 118, no. 4, pp. 661-669, 2000.
88. T. Havelund, L. S. Laursen, E. Skoubo-Kristensen, et al, "Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial," British Medical Journal, vol. 296, no. 6615, pp. 89-92, 1988.
89. M. Khan, J. Santana, C. Donnellan, et al., "Medical treatment in the short term management of reflux oesophagitis," Cochrane Database of Systematic Reviews, vol. 2, Article ID CD003244, 2007.
90. D. A. Johnson, S. B. Benjamin, N. B. Vakil, et al., "Esomeprazole once daily for 6 months is effective therapy for maintening healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, doubleblind, placebo-controlled study of efficacy and safety," The American Journal of Gastroenterology, vol. 96, pp. 27-34, 2001.
91. D. O. Castell, P. J. Kahrilas, D. A. Johanson, et al., "Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis," The American Journal of Gastroenterology, vol. 97, no. 3, pp. 575-583, 2002.
92. P. B. Amidon, R. Jankovich, C. A. Stoukides, et al, "Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program," American Journal of Managed Care, vol. 6, no. 5, pp. 593-601, 2000.
93. T. L. Venables, R. D. Newland, A. C. Patel, et al, "Omeprazole 10 mg once daily, omeprazole 20 mg once daily or ranitidine 150 mg twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice," Scandinavian Journal of Gastroenterology, vol. 32, pp. 965-973, 1997.
94. B. van Pinxteren, M. E. Numans, P. A. Bonis, et al., "Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease," Cochrane Database of Systematic Reviews, vol. 3, Article ID CD002095, 2006.
95. J. E. Richter, "The patient with refractory gastroesophageal reflux disease," Diseases of the Esophagus, vol. 19, no. 6, pp. 443-447, 2006.
96. S. D. Martinez, I. B. Malagon, H. S. Garewel, et al, "Nonerosive reflux disaese (NERD)-acid reflux and symptom patterns," Alimentary Pharmacology & Therapeutics, vol. 17, pp. 537-545, 2003.
97. S. Emerenziani, D. Sifrim, F. I. Habib, et al., "Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus," Gut, vol. 57, no. 4, pp. 443-447, 2008.
98. R. Fass, "Proton pump inhibitor failure-what are the therapeutic options?" The American Journal of Gastroenterology, vol. 104, pp. S33-S38, 2009.
99. B receptors as drug targets to treat gastroesophageal reflux disease," Pharmacology and Therapeutics, vol. 122, no. 3, pp. 239-245, 2009.
100. I. Mainie, R. Tutuian, A. Agrawal, et al., "Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication," British Journal of Surgery, vol. 93, no. 12, pp. 1483-1487, 2006.
101. B. van Pinxteren, M. M. E. Numans, P. Bonis, J. Lau, and K. Sigterman, "Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease," Cochrane Database of Systematic Reviews, vol. 3, Article ID CD002095, 2006.
102. N. Vakil, "Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease," Alimentary Pharmacology & Therapeutics,vol. 19, no. 10, pp. 1041-1049, 2004.
103. P. J. Kahrilas, E. M. Quigley, D. O. Castell, and S. J. Spechler, "The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease," Alimentary Pharmacology & Therapeutics, vol. 14, no. 11, pp. 1503-1509, 2000.
104. C. Donnellan, P. Moayyedi, C. Preston, and N. Sharma, "Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease," Cochrane Database of Systematic Reviews, vol. 2, Article ID CD003245, 2005.
105. J. Zacny, M. Zamakhshary, I. Sketris, and V. Van Zanten, "Systematic review: the efficacy of intermittent and ondemand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease," Alimentary Pharmacology & Therapeutics, vol. 21, no. 11, pp. 1299-1312, 2005.
106. F. Pace, M. Tonini, S. Pallotta, et al., "Systematic review: maintenance treatment of gastroesophageal reflux disease with proton pump inhibitor taken "on-demand"," Alimentary Pharmacology & Therapeutics, vol. 26, pp. 195-204, 2007.
107. G.N. Tytgat, K. McColl, J. Tack, et al., "New algorithm for the treatment of gastro-oesophageal reflux disease," Alimentary Pharmacology & Therapeutics, vol. 27, no. 3, pp. 249-256, 2008.
108. L. Laine, D. Ahnen, C. McClain, et al., "Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors," Alimentary Pharmacology & Therapeutics, vol. 14, no. 6, pp. 651-668, 2000.
109. S. Dial, K. Alrasadi, C. Manoukian, et al., "Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies," Canadian Medical Association Journal, vol. 171, no. 1, pp. 33-38, 2004.
110. L. Laine, "Proton pump inhibitors and bone fractures?" The American Journal of Gastroenterology, vol. 104, pp. S21-S26, 2009.
111. M. B. O'Connell, D. M. Madden, A. M. Murray, et al., "Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial," American Journal of Medicine, vol. 118, no. 7, pp. 778-781, 2005.
112. P. R. Allison, "Reflux esophagitis, sliding hiatal hernia, and the anatomy of repair," Surgery Gynecology & Obstetrics, vol. 92, pp. 419-431, 1951.
113. R. A. Hinder, C. J. Filipi, G. Wetscher, et al., "Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease," Annals of Surgery, vol. 220, no. 4, pp. 472-483, 1994.
114. S. Horgan and C. A. Pellegrini, "Surgical treatment of gastroesophageal reflux disease," Surgical Clinics of North America, vol. 77, no. 5,pp. 1063-1082, 1997.
115. T. R. DeMeester, E. Lafontaine, B. E. Joelsson, et al., "Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction," Journal of Thoracic and Cardiovascular Surgery, vol. 82, no. 4, pp. 547-558, 1981.
116. J. H. Peters, T. R. DeMeester, P. Crookes, et al., "The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with typical' symptoms," Annals of Surgery, vol. 228, no. 1, pp. 40-50, 1998.
117. O. Korn, A. Csendes, P. Burdiles, et al, "Anatomic dilatation of the cardia and competence of the lower esophageal sphincter: a clinical and experimental study," Journal of Gastrointestinal Surgery, vol. 4, no. 4, pp. 398-406, 2000.
118. M. Luostarinen, J. Isolauri, J. Laitinen, et al., "Fate of Nissen fundoplication after 20 years. A clinical, endoscopical, and functional analysis," Gut, vol. 34, no. 8, pp. 1015-1020, 1993.
119. J. Johansson, F. Johnsson, B. Joelsson, C. H. Floren, and B. Walther, "Outcome 5 years after 360° fundoplication for gastroesophageal reflux disease," British Journal of Surgery, vol. 80, no. 1, pp. 46-49, 1993.
120. L. Rydberg, M. Ruth, and L. Lundell, "Mechanism of action of antireflux procedures," British Journal of Surgery, vol. 86, no. 3, pp. 405-410, 1999.
121. H. B. El-Serag, "The epidemic of esophageal carcinoma," Gastroenterology Clinics of North America, vol. 31, pp. 421-440, 2002.
122. T. R. DeMeester and L. F. Johnson, "Evaluation of the Nissen antireflux procedure by esophageal manometry and twenty four hour pH monitoring," American Journal of Surgery, vol. 129, no. 1, pp. 94-100, 1975.
123. R. C. Orlando, "Overview of the mechanisms of gastroesophageal reflux," The American Journal of Medicine, vol. 111, supplement 8A, pp. 174S-177S, 2001.
124. G. R. Locke III, N. J. Talley, S. L. Fett, A. R. Zinsmeister, and L. J. Melton III, "Risk factors associated with symptoms of gastroesophageal reflux," The American Journal of Medicine, vol. 106, pp. 642-649, 1999.
125. C. Hagedorn, H. Lonroth, L. Rydberg, M. Ruth, and L. Lundell, "Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet) fundoplication: results of a randomized clinical trial," Journal of Gastrointestinal Surgery, vol. 6, no. 4, pp. 540-545, 2002.
126. L. Rydberg, M. Ruth, H. Abrahamsson, and L. Lundell, "Tailoring antireflux surgery: a randomized clinical trial," World Journal of Surgery, vol. 23, no. 6, pp. 612-618, 1999.
127. J. G. Hunter, L. Swanstrom, and J. P. Waring, "Dysphagia after laparoscopic antireflux surgery: the impact of operative technique," Annals of Surgery, vol. 224, no. 1, pp. 51-57, 1996.
128. D. R. Flum, T. Koepsell, P. Heagerty, et al., "The nationwide frequency of major adverse outcomes in antireflux surgery and the role of surgeon experience, 1992-1997," Journal of the American College of Surgeons, vol. 195, no. 5, pp. 611-618, 2002.
129. J. Y. Mabrut, J. Baulieux, M. Adham, et al., "Impact of antireflux operation on columnar-lined esophagus," Journal of the American College of Surgeons, vol. 196, no. 1, pp. 60-67, 2003.
130. G. J. Wetscher, M. Gadenstaetter, P. J. Klingler, et al., "Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease," Annals of Surgery, vol. 234, no. 5, pp. 627-632, 2001.
131. A. Csendes, I. Braghetto, P. Burdiles, et al., "Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation," Surgery, vol. 123, no. 6, pp. 645-657, 1998.
132. M. L. MacDonald, V. F. Trastek, M. S. Allen, et al., "Barrett's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance?" The Journal of Thoracic and Cardiovascular Surgery, vol. 111, pp. 1135-1140, 1996.
133. S. R. DeMeester and T. R. DeMeester, "Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy," Annals of Surgery, vol. 231, no. 3, pp. 303-321, 2000.
134. D. I. Watson, G. C. Mayne, and D. J. Hussey, "Barrett's esophagus, fundoplication, and cancer," World Journal of Surgery, vol. 31, no. 3, pp. 447-449, 2007.
135. R. Ackroyd, D. I. Watson, A. W. Majeed, G. Troy, P. J. Treacy, and C. J. Stoddard, "Randomized clinical trial of laparoscopic versus open fundoplication for gastro-oesophageal reflux disease," British Journal of Surgery, vol. 91, no. 8, pp. 975-982, 2004.
136. T. Geagea, "Laparoscopic Nissen's fundoplication: preliminary report on ten cases," Surgical Endoscopy, vol. 5, no. 4, pp. 170-173, 1991.
137. B. Dallemagne, J. M. Weerts, C. Jehaes, S. Markiewicz, and R. Lombard, "Laparoscopic Nissen fundoplication: preliminary report," Surgical Laparoscopy & Endoscopy, vol. 1, no. 3, pp. 138-143, 1991.
138. T. Kamolz, F. A. Granderath, T. Bammer, H. Wykypiel Jr., and R. Pointner, "Floppy' Nissen vs. Toupet laparoscopic fundoplication: quality-of-life assessment in a 5-year followup (part 2)," Endoscopy, vol. 34, pp. 917-922, 2002.
139. D. I. Watson, G. G. Jamieson, P. G. Devitt, P. C. Mitchell, and P. A. Game, "Paraesophageal hiatus hernia: an important complication of laparoscopic Nissen fundoplication," The British Journal of Surgery, vol. 82, pp. 521-523, 1995.
140. J. G. Hunter, C. D. Smith, G. D. Branum, et al., "Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision," Annals of Surgery, vol. 230, no. 4, pp. 595-606, 1999.
141. L. Lundell, "Complications after anti-reflux surgery," Best Practice and Research & Clinical Gastroenterology, vol. 18, no. 5, pp. 935-945, 2004.
142. J. E. Bais, J. F. W. M. Bartelsman, H. J. Bonjer, et al., "Laparoscopic or conventional Nissen fundoplication for gastro-esophageal reflux disease: randomized clinical trial," The Lancet, vol. 355, pp. 170-174, 2000.
143. J. A. Dominitz, C. A. Dire, K. G. Billingsley, et al., "Complications and antireflux medication use after antireflux surgery," Clinical Gastroenterology and Hepatology, vol. 4, no. 3, pp. 299-305, 2006.
144. M. Anvari and C. Allen, "Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication," Journal of the American College of Surgeons, vol. 196, no. 1, pp. 51-57, 2003.
145. G. Nilsson, J. Wenner, S. Larsson, and F. Johnsson, "Randomized clinical trial of laparoscopic versus open fundoplication for gastro-oesophageal reflux," British Journal of Surgery, vol. 91, no. 5, pp. 552-559, 2004.
146. B. Dallemagne, J. Weerts, S. Markiewicz, et al., "Clinical results of laparoscopic fundoplication at ten years after surgery," Surgical Endoscopy, vol. 20, no. 1, pp. 159-165, 2006.
147. C. Zornig, U. Strate, C. Fibbe, A. Emmermann, and P. Layer, "Nissen vs Toupet laparoscopic fundoplication: a prospective randomized study of 200 patients with and without preoperative esophageal motility disorders," Surgical Endoscopy, vol. 16, no. 5, pp. 758-766, 2002.
148. D. I. Watson and G. G. Jamiesson, "Antireflux surgery in the laparoscopic era," The British Journal of Surgery, vol. 85, pp. 1173-1184, 1998.
149. S. Horgan, D. Pohl, D. Bogetti, T. Eubanks, and C. Pellegrini, "Failed antireflux surgery: what have we learned from reoperations?" Archives of Surgery, vol. 134, pp. 809-815, 1999.
150. J. P. Byrne, B. M. Smithers, L. K. Nathanson, et al., "Symptomatic and functional outcome after laparoscopic reoperation for failed antireflux surgery," British Journal of Surgery, vol. 92, no. 8, pp. 996-1001, 2005.
151. P. K. Papasavas, R. J. Keenan, W. W. Yeaney, P. F. Caushaj, D. J. Gagne, and R. J. Landreneau, "Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy," Surgical Endoscopy, vol. 17, pp. 1200-1205, 2003.
152. E. Chrysos, J. Tsiaoussis, E. Athanasakis, O. Zoras, J. S. Vassilakis, and E. Xynos, "Laparoscopic vs open approach for Nissen fundoplication: a comparative study," Surgical Endoscopy, vol. 16, no. 12, pp. 1679-1684, 2002.
153. Y. K. Chen, I. Raijman, T. Ben-Menachem, et al., "Long-term outcomes of endoluminal gastroplication: a U.S. multicenter trial," Gastrointestinal Endoscopy, vol. 61, no. 6, pp. 659-667, 2005.
154. S. Ozawa, K. Kumai, K. Higuchi, et al., "Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan," Journal of Gastroenterology, vol. 44, no. 7, pp. 675-684, 2009.
155. D. Pleskow, R. Rothstein, R. Kozarek, et al., "Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results," Surgical Endoscopy, vol. 21, no. 3, pp. 439-444, 2007.
156. Z. Mahmood and Y. S. Ang, "EndoCinch treatment for gastro-oesophageal reflux disease," Digestion, vol. 76, no. 3-4, pp. 241-247, 2007.
157. R. Rothstein, C. Filipi, K. Caca, et al., "Endoscopie fullthickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial," Gastroenterology, vol. 131, no. 3, pp. 704-712, 2006.
158. G. B. Cadiere, A. Rajan, M. Rqibate, et al., "Endoluminal fundoplication (ELF) - evolution of EsophyX, a new surgical device for transoral surgery," Minimally Invasive Therapy and Allied Technologies, vol. 15, no. 6, pp. 348-355, 2006.
159. G. B. Cadiere, A. Rajan, O. Germay, and J. Himpens, "Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study," Surgical Endoscopy, vol. 22, no. 2, pp. 333-342, 2008.
160. S. J. Spechler, E. Lee, D. Ahnen, et al., "Long-term outcome of
161. L. Lundell, "Laparoscopic fundoplication is the treatment of choice for gastroesophageal reflux disease. Protagonist," Gut, vol. 51, no. 4, pp. 468-471, 2002.
162. J. P. Galmiche and F. Zerbib, "Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Antagonist," Gut, vol. 51, no. 4, pp. 472-474, 2002.
163. D. Mahon, M. Rhodes, B. Decadt, et al., "Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastroesophageal reflux," British Journal of Surgery, vol. 92, no. 6, pp. 695-699, 2005.
164. C. B. Morgenthal, M. D. Shane, A. Stival, et al., "The durability of laparoscopic Nissen fundoplication: 11 year outcomes," Journal of Gastrointestinal Surgery, vol. 11, no. 6, pp. 693-700, 2007.
165. S. Mehta, J. Bennett, D. Mahon, and M. Rhodes, "Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up," Journal of Gastrointestinal Surgery, vol. 10, no. 9, pp. 1312-1317, 2006.
166. K. P. Balsara, C. R. Shah, and M. Hussain, "Laparoscopic fundoplication for gastroesophageal reflux disease: an 8 year experience," Journal of Minimal Access Surgery, vol. 4, no. 4, pp. 99-103, 2008.
167. L. Lundell, P. Miettinen, H. E. Myrvold, et al., "Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis," British Journal of Surgery, vol. 94, no. 2, pp. 198-203, 2007.
168. B. K. Oelschlager and C. A. Pellegrini, "Laparoscopic treatment of Barrett's esophagus," Disease-A-Month, vol. 50, no. 11, pp. 580-590, 2004.
169. K. E. Corey, S. M. Schmitz, and N. J. Shaheen, "Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A metaanalysis," The American Journal of Gastroenterology, vol. 98, pp. 2390-2394, 2003.
170. C. J. Allen and M. Anvari, "Does laparoscopic fundoplication provides long-term control of gastroesophageal reflux related cough?" Surgical Endoscopy, vol. 18, pp. 633-637, 2004.
171. S. J. Sontag, S. O'Connell, S. Khandelwal, et al., "Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies," The American Journal of Gastroenterology, vol. 98, no. 5, pp. 987-999, 2003.
172. R. Rothstein, C. Filipi, K. Caca, et al, "Endoscopic fullthickness plication for the treatment of gastroesophageal reflux disease: a randomized, sham-controlled trial," Gastroenterology, vol. 131, no. 3, pp. 704-712, 2006.